Rossmore Private Capital Oramed Pharmaceuticals Inc. Transaction History

Rossmore Private Capital

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$8.19 - $13.89 $92,899 - $157,554	-11,343 Reduced 21.81%	40,661 $352,000
Q4 2021 Feb 07, 2022	BUY	$12.98 - $29.75 $64,900 - $148,750	5,000 Added 10.64%	52,004 $743,000
Q3 2021 Nov 08, 2021	BUY	$12.13 - $23.82 $387,468 - $760,882	31,943 Added 212.09%	47,004 $1.03 Million
Q4 2017 Mar 15, 2018	BUY	$7.95 - $11.15 $119,734 - $167,930	15,061	15,061 $136 Million

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

Stay updated on Rossmore Private Capital with notifications on news.